Inhibrx Biosciences Insider Bought Shares Worth $998,784, According to a Recent SEC Filing
MT newswire2026/09/28 21:52Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
05:52 PM EDT, 09/28/2026 (MT Newswires) -- Mark Lappe, Director, Chief Executive Officer, on September 25, 2026, executed a purchase for 10,000 shares in Inhibrx Biosciences (INBX) for $998,784. Following the Form 4 filing with the SEC, Lappe has control over a total of 960,413 common shares of the company, with 960,413 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2007919/000136607426000004/xslF345X05/wk-form4_1790632047.xml
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Meta Stock Warning? Zuckerberg Sells $21 Million as Insiders Exit
BeInCrypto•2026/10/11 15:03
A List of the 15 Altcoins Most Searched for in Recent Hours Has Been Published
BitcoinSistemi•2026/10/11 12:24
Crypto prices
More
Bitcoin
BTC
$83,045.53
+0.20%
Ethereum
ETH
$2,504.61
-0.04%
Tether USDt
USDT
$0.9990
-0.01%
BNB
BNB
$749.51
-0.28%
XRP
XRP
$1.4
-0.53%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$109.62
-0.74%
TRON
TRX
$0.3300
-0.30%
Hyperliquid
HYPE
$85.69
-0.72%
Zcash
ZEC
$1,228.22
-0.66%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now